28 results
6-K
EX-99.1
HCM
HUTCHMED (China) Limited
2 Apr 24
Current report (foreign)
6:03am
.
Koppikar S, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer
6-K
EX-99.1
HCM
HUTCHMED (China) Limited
1 Dec 23
HUTCHMED Highlights Clinical Data to be Presented at 2023 ESMO Asia and ESMO Immuno-Oncology Congresses
6:03am
colorectal cancer: Asian vs non-Asian outcomes in FRESCO-2
Lead Author:
Daisuke Kotani, National Cancer Center Hospital East Kashiwa, Japan
Abstract # & Link …
This presentation will report efficacy and safety data according to race for Asian and non-Asian patient subgroups from the FRESCO-2 study. FRESCO-2
6-K
EX-99.1
HCM
HUTCHMED (China) Limited
20 Jul 23
Current report (foreign)
6:33am
-e17613. DOI: 10.1200/JCO.2023.41.16_suppl.e17613.
5 Koppikar S, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis
6-K
EX-99.1
HCM
HUTCHMED (China) Limited
18 Apr 23
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
6:05am
for gastric cancer patients. Gastric cancer is one of the most common cancers globally, with the highest incidence and mortality rates found in Asian
6-K
EX-99.1
41rxwpdvcw26eabo8
14 Nov 22
HUTCHMED Announces Positive Topline Result in Fruquintinib Phase III FRUTIGA Study in Second-Line Gastric Cancer in China
6:14am
6-K
EX-99.1
5r38rr56ooy2in3ns6mj
9 Aug 21
HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China
6:42am
6-K
dvoxjrv9
21 Jun 21
HUTCHMED (China) Limited Supplemental and Updated Disclosures
6:27am
6-K
EX-99.1
cq92cms4hsdafqmut
21 Jun 21
HUTCHMED (China) Limited Supplemental and Updated Disclosures
6:27am
6-K
EX-99.1
5821te
17 May 21
Current report (foreign)
6:13am
424B5
tp3k phgbwmu6iay5
23 Jan 20
Prospectus supplement for primary offering
6:19am
424B5
ecllw2olo9f k4
21 Jan 20
Prospectus supplement for primary offering
4:53pm
424B7
yv79dh6ob2927
30 Sep 19
Prospectus with selling stockholder info
11:24am
424B7
msb3zak8gu qk
30 Sep 19
Prospectus with selling stockholder info
7:58am
424B7
bv8bl
2 Jul 19
Prospectus with selling stockholder info
8:03am
424B7
g97cxdoj z4
27 Jun 19
Prospectus with selling stockholder info
4:39pm